MetaCap

Apimeds Pharmaceuticals US Inc. (APUS)

NYSE: APUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.60-0.14 (-8.05%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

APUS stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$12.69
52-week range
1.51 – 59.70
Day range
1.51 – 1.77
Volume / Avg
48.55K / 3.73M
Beta
—

52-week range

$1.51$59.70

APUS stock today

On Nov 20, APUS ended the session at $1.60, shedding $0.14 (8.05%), versus the S&P 500's 3.70% decline. Trading was light, with 48.55K shares changing hands, about 1% of the average daily volume. Shares are 97.3% below their 52-week high of $59.70, set on May 5, 2026 and 6.0% above the 52-week low of $1.51, near the bottom of the past year's range.

APUS is down 90.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 93.0%. Apimeds Pharmaceuticals US has posted a net loss over the last twelve months (EPS of -$12.69), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Apimeds Pharmaceuticals US

Company profile

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey.

Industry
Biotechnology: Pharmaceutical Preparations
Headquarters
Matawan, NJ
IPO year
2025

Financial highlights

Full financials

Apimeds Pharmaceuticals US reported a net loss of $6.0 million, compared with a loss of $1.4 million a year earlier. Diluted earnings per share came in at -$0.55.

Apimeds Pharmaceuticals US annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023
Revenue———
Growth———
Net income$-6.00M$-1.39M$-777.69K
EPS (diluted)$-0.55$-0.18$-0.17

Earnings

Earnings history
Last reported (Sep/2026)
Nov 16, 2026
EPS actual vs est.
$0.29 vs —

APUS news

All APUS news

Apimeds Pharmaceuticals US peers

Health Care sector
APUS peer companies
CompanyPrice% ChgMarket capCompare
JAGXJaguar Health Inc.0.227-30.58%$3.03Mvs APUS
SKYESkye Bioscience Inc.0.70-11.03%$3.10Mvs APUS
GELSGelteq Limited0.2701-3.74%$3.11Mvs APUS
AZTRAzitra Inc0.5168-2.75%$3.13Mvs APUS
MDCXMedicus Pharma Ltd.1.14-2.16%$3.16Mvs APUS
KPRXKiora Pharmaceuticals Inc.0.7202-12.28%$3.19Mvs APUS
NRSNNeuroSense Therapeutics Ltd.1.28+1.59%$3.19Mvs APUS
TRAWTraws Pharma Inc.0.175-23.91%$2.69Mvs APUS

Indexes, lists and sector

Apimeds Pharmaceuticals US stock FAQ

What is Apimeds Pharmaceuticals US's stock price today?

APUS last traded at $1.60 as of Nov 20, 4:00 PM EST, down 8.05% on the day. Prices are delayed at least 15 minutes.

Does Apimeds Pharmaceuticals US pay a dividend?

No. Apimeds Pharmaceuticals US does not currently pay a regular cash dividend.

Has APUS ever split its stock?

Yes. The most recent APUS stock split was a 1-for-10 split on Jul 24, 2026.

What is the APUS 52-week high?

The 52-week high for APUS is $59.70 and the 52-week low is $1.51. The stock is currently 97.3% below its high.

Compare APUS